Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alternative lengthening of telomere-based immortalization renders H3G34R -mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.
Laemmerer A, Lehmann C, Mayr L, Bruckner K, Gabler L, Senfter D, Meyer P, Balber T, Pirker C, Jaunecker CN, Kirchhofer D, Vician P, Griesser M, Spiegl-Kreinecker S, Schmook MT, Traub-Weidinger T, Kuess P, Eckert F, Federico A, Madlener S, Stepien N, Robl B, Baumgartner A, Hainfellner JA, Dieckmann K, Dorfer C, Roessler K, Corsini NS, Holzmann K, Schmidt WM, Peyrl A, Azizi AA, Haberler C, Beck A, Pfister SM, Schueler J, Loetsch-Gojo D, Knoblich JA, Berger W, Gojo J. Laemmerer A, et al. Among authors: gojo j. Neuro Oncol. 2024 Nov 18:noae228. doi: 10.1093/neuonc/noae228. Online ahead of print. Neuro Oncol. 2024. PMID: 39556024
Real-World Performance of Integrative Clinical Genomics in Pediatric Precision Oncology.
Pokorna P, Palova H, Adamcova S, Jugas R, Al Tukmachi D, Kyr M, Knoflickova D, Kozelkova K, Bystry V, Mejstrikova S, Merta T, Trachtova K, Podlipna E, Mudry P, Pavelka Z, Bajciova V, Tinka P, Jarosova M, Catela Ivkovic T, Madlener S, Pal K, Stepien N, Mayr L, Tichy B, Drabova K, Jezova M, Kozakova S, Vanackova J, Radova L, Steininger K, Haberler C, Gojo J, Sterba J, Slaby O. Pokorna P, et al. Among authors: gojo j. Lab Invest. 2024 Oct 21;104(12):102161. doi: 10.1016/j.labinv.2024.102161. Online ahead of print. Lab Invest. 2024. PMID: 39442669 Free article.
CNS Embryonal Tumor with PLAGL Amplification, a New Tumor Type in Children and Adolescents: Insights from a Comprehensive MRI Analysis.
Tietze A, Bison B; European Society for Paediatric Oncology (SIOPE)-Brain Tumour Group; Engelhardt J, Fenouil T, Figarella-Branger D, Goebell E, Hakumäki J, Koscielniak E, Ludlow LE, Meyronet D, Nyman P, Øra I, Pesola J, Rauramaa T, Reddingius RE, Samuel D, Sexton-Oates A, Vasiljevic A, Wefers AK, Zamecnik J, Jones D, Keck MK, von Hoff K. Tietze A, et al. AJNR Am J Neuroradiol. 2024 Sep 13:ajnr.A8496. doi: 10.3174/ajnr.A8496. Online ahead of print. AJNR Am J Neuroradiol. 2024. PMID: 39271290
GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant.
Liu I, Alencastro Veiga Cruzeiro G, Bjerke L, Rogers RF, Grabovska Y, Beck A, Mackay A, Barron T, Hack OA, Quezada MA, Molinari V, Shaw ML, Perez-Somarriba M, Temelso S, Raynaud F, Ruddle R, Panditharatna E, Englinger B, Mire HM, Jiang L, Nascimento A, LaBelle J, Haase R, Rozowsky J, Neyazi S, Baumgartner AC, Castellani S, Hoffman SE, Cameron A, Morrow M, Nguyen QD, Pericoli G, Madlener S, Mayr L, Dorfer C, Geyeregger R, Rota C, Ricken G, Ligon KL, Alexandrescu S, Cartaxo RT, Lau B, Uphadhyaya S, Koschmann C, Braun E, Danan-Gotthold M, Hu L, Siletti K, Sundström E, Hodge R, Lein E, Agnihotri S, Eisenstat DD, Stapleton S, King A, Bleil C, Mastronuzzi A, Cole KA, Waanders AJ, Montero Carcaboso A, Schüller U, Hargrave D, Vinci M, Carceller F, Haberler C, Slavc I, Linnarsson S, Gojo J, Monje M, Jones C, Filbin MG. Liu I, et al. Among authors: gojo j. Cancer Cell. 2024 Aug 27:S1535-6108(24)00305-2. doi: 10.1016/j.ccell.2024.08.006. Online ahead of print. Cancer Cell. 2024. PMID: 39232581 Free article.
Distinct relapse pattern across molecular ependymoma types.
Obrecht-Sturm D, Schoof M, Eckhardt A, Mynarek M, Gilbert MR, Aldape K, Armstrong TS, Ramaswamy V, Bockmayr M, von Hoff K, Fleischhack G, Adolph JE, Tippelt S, Pfister SM, Pajtler K, Sturm D, Drexler R, Ricklefs FL, Stepien N, Gojo J, Pietsch T, Warmuth-Metz M, Kortmann R, Timmermann B, Haberler C, Rutkowski S, Schüller U. Obrecht-Sturm D, et al. Among authors: gojo j. Neuro Oncol. 2024 Aug 22:noae166. doi: 10.1093/neuonc/noae166. Online ahead of print. Neuro Oncol. 2024. PMID: 39171767
Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngioma.
Hedrich C, Patel P, Haider L, Taylor T, Lau E, Hook R, Dorfer C, Roessler K, Stepien N, Lippolis MA, Schned H, Koeller C, Mayr L, Azizi AA, Peyrl A, Lopez BR, Lassaletta A, Bennett J, Gojo J, Bartels U. Hedrich C, et al. Among authors: gojo j. Front Oncol. 2024 Jul 10;14:1401761. doi: 10.3389/fonc.2024.1401761. eCollection 2024. Front Oncol. 2024. PMID: 39050573 Free PMC article.
Asking those who know their needs best: A framework for active engagement and involvement of childhood cancer survivors and parents in the process of psychosocial research-A workshop report.
Weiler-Wichtl LJ, Schneider C, Gsell H, Maletzky AM, Kienesberger A, Röhl C, Bocolli A, Gojo J, Hansl R, Zettl A, Hopfgartner M, Leiss U. Weiler-Wichtl LJ, et al. Among authors: gojo j. Cancer Rep (Hoboken). 2024 May;7(5):e2071. doi: 10.1002/cnr2.2071. Cancer Rep (Hoboken). 2024. PMID: 38767531 Free PMC article.
71 results